Table 2 Health-related quality of life of patients with localized scleroderma
Mean (SD) | Median (IQR) | Range | |
|---|---|---|---|
Skindex-29 | |||
Symptoms | 14.35 (±5.11) | 13 (11–18.25) | 7–28 |
Function | 19.15 (±8.39) | 16 (13–21.75) | 12–53 |
Emotions | 23.10 (±8.48) | 21 (17–26) | 11–50 |
Short-form 36 | |||
PCS | 42.24 (±8.29) | 44.70 (37.43–48.34) | 23.14–54.16 |
PF | 48.26 (±9.06) | 51.80 (44.15–55.63) | 25.01–57.54 |
RP | 26.84 (±3.60) | 27.96 (23.47–30.21) | 21.23–30.21 |
BP | 45.13 (±13.37) | 46.68 (37.00–55.55) | 21.68–62.00 |
GH | 38.10 (±5.57) | 38.92 (35.24–41.90) | 26.08–46.07 |
MCS | 41.04 (±7.42) | 40.82 (35.28–44.58) | 27.58–67.47 |
VT | 50.82 (±8.58) | 49.63 (43.69–56.31) | 34.77–70.42 |
SF | 47.57 (±11.29) | 49.82 (42.30–57.34) | 7.29–57.34 |
RE | 22.74 (±6.77) | 24.83 (17.87–24.83) | 14.39–56.17 |
MH | 48.38 (±8.31) | 48.25 (45.64–53.48) | 27.32–63.95 |